0001192482-21-000211.txt : 20210303
0001192482-21-000211.hdr.sgml : 20210303
20210303200150
ACCESSION NUMBER: 0001192482-21-000211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180112
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fleming Alison B
CENTRAL INDEX KEY: 0001640701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 21711846
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-01-12
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001640701
Fleming Alison B
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
0
1
0
0
Chief Technical Officer
Common Stock
2018-01-12
4
M
0
1747
0.9
A
157911
D
Common Stock
2018-01-12
4
S
0
1747
21
D
156164
D
Common Stock
2018-01-12
4
M
0
5753
0.48
A
161917
D
Common Stock
2018-01-12
4
S
0
5753
21
D
156164
D
Common Stock
2018-01-19
4
M
0
64
0.9
A
156228
D
Common Stock
2018-01-19
4
S
0
64
23
D
156164
D
Common Stock
2018-01-19
4
M
0
1811
0.9
A
157975
D
Common Stock
2018-01-19
4
S
0
1811
23
D
156164
D
Common Stock
2018-01-19
4
M
0
1449
3.31
A
157613
D
Common Stock
2018-01-19
4
S
0
1449
23
D
156164
D
Common Stock
2018-05-10
4
S
0
1400
27
D
154764
D
Common Stock
2021-03-01
4
S
0
6011
23.36
D
148753
D
Stock Option (Right to Purchase)
0.9
2018-01-12
4
M
0
1747
0
D
2019-04-23
Common Stock
1747
64
D
Stock Option (Right to Purchase)
0.48
2018-01-12
4
M
0
5753
0
D
2023-01-24
Common Stock
5753
0
D
Stock Option (Right to Purchase)
0.9
2018-01-19
4
M
0
64
0
D
2019-04-23
Common Stock
64
0
D
Stock Option (Right to Purchase)
0.9
2018-01-19
4
M
0
1811
0
D
2020-02-26
Common Stock
1811
0
D
Stock Option (Right to Purchase)
3.31
2018-01-19
4
M
0
1449
0
D
2021-02-08
Common Stock
1449
0
D
Certain transactions reported in this Form 4 are late due to an administrative error.
The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018.
The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020.
The option was fully vested and exercisable as of January 12, 2018.
The option was fully vested and exercisable as of January 19, 2018.
/s/ Paul Brannelly as Attorney-In-Fact For Alison B. Fleming
2021-03-03